Trib2 Suppresses Tumor Initiation in Notch-Driven T-ALL

Area of Science:

• Oncology
• Molecular Biology
• Hematology

Background:

• Trib2 is highly expressed in human T cell acute lymphoblastic leukemia (T-ALL) and is a target of oncogenic drivers Notch and TAL1.
• Its role as a survival factor in T-ALL is proposed but not well-defined in primary T-ALL.
• Limited information exists on Trib2's function in the initiation and maintenance of Notch-dependent T-ALL.

Purpose of the Study:

• To investigate the role of Trib2 in the initiation and maintenance of Notch-dependent T-ALL.
• To determine Trib2's effect on leukemogenesis in vivo using Trib2 knockout mice.
• To analyze Trib2 expression patterns in different T-ALL subtypes.

Main Methods:

• In vitro studies using shRNAs to block Trib2 expression in murine T-ALL cell lines.
• Generation of Trib2 knockout mice to assess in vivo leukemogenesis.
• Retroviral modeling of Notch-induced T-ALL in Trib2 knockout mice.
• Immunoblotting to analyze protein expression (C/EBPα, AKT, ERK) in primary murine T-ALL cells.
• Transcriptomic analysis of human T-ALL cohorts.

Main Results:

• Trib2 inhibition had no effect on murine T-ALL cell growth or survival in vitro.
• Trib2 knockout mice showed normal development and hematopoiesis.
• Deletion of Trib2 accelerated T-ALL development and increased its penetrance in a Notch-induced T-ALL model.
• Absence of Trib2 led to increased C/EBPα expression in primary murine T-ALL cells.
• Low Trib2 expression correlated with the TLX1-expressing T-ALL subtype, while high Trib2 expression correlated with the LYL1-expressing T-ALL subtype.

Conclusions:

• Trib2 plays a complex role in Notch-driven T-ALL pathogenesis.
• Trib2's function in T-ALL may differ across subtypes, with low expression linked to mature subtypes and high expression to immature subtypes.
• Trib2 is not essential for normal hematopoiesis or T cell development.